All In Biotech

Drug Trial Radar · NCT00601003

Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma

A Phase II Trial of Nifurtimox for Refractory or Relapsed Neuroblastoma or Medulloblastoma.

Last checked: Nov 20, 2026Latest source record: Aug 6, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

112

Actual

Start

Jan 14, 2008

Primary completion

Apr 28, 2020

Study completion Oct 28, 2022

Sponsor

Lead sponsor
Giselle ShollerAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Bayer
First posted
Jan 25, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, up to 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether nifurtimox in combination with cyclophosphamide and topotecan are effective in the treatment of relapsed or refractory neuroblastoma and medulloblastoma.

Conditions

  • Neuroblastoma
  • Medulloblastoma

Interventions

  • NifurtimoxDrug

    30mg/kg/day PO divided into TID dosing q day

  • CyclophosphamideDrug

    250 mg/m2/dose in normal saline, IV, infused over 30 minutes on days 1-5 of each cycle.

  • TopotecanDrug

    0.75mg/m2/dose, in normal saline, IV, infused over 30 minutes on days 1-5 of each cycle.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Related Adverse Events as a Measure of Safety and TolerabilityTime frame: 2 years
  2. Best Radiological Response in Participants Using the RECIST CriteriaTime frame: 2 years

Locations

15 sites in 1 country. Site status is shown where the registry gives one.

  • Rady Children's Hospital

    San Diego, California

  • Connecticut Children's Hospital

    Hartford, Connecticut

  • Arnold Palmer Hospital for Children- MD Anderson

    Orlando, Florida

  • Kapiolani Medical Center for Women and Children

    Honolulu, Hawaii

  • Tufts Medical Center

    Boston, Massachusetts

  • Helen DeVos Children's Hospital

    Grand Rapids, Michigan

  • Children's Hospital and Clinics on Minnesota

    Minneapolis, Minnesota

  • Children's Mercy Hospitals and Clinics

    Kansas City, Missouri

  • Cardinal Glennon Children's Medical Center

    St Louis, Missouri

  • Levine Children's Hospital

    Charlotte, North Carolina

  • Penn State Milton S. Hershey Medical Center and Children's Hospital

    Hershey, Pennsylvania

  • Medical University of South Carolina

    Charleston, South Carolina

  • Children's Medical Center

    Dallas, Texas

  • Texas Children's Cancer and Hematology Centers

    Houston, Texas

  • Primary Children's Hospital

    Salt Lake City, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.